Suppression of paraquat-induced wet dog shakes by nitric oxide synthase inhibitors in rats. 2000

S Hara, and T Mukai, and T Kuriiwa, and T Yanase, and K Kurosaki, and S Kano, and T Endo
Department of Forensic Medicine, Tokyo Medical University, Japan. s-hara@tokyo-med.ac.jp

We have found that paraquat (PQ), a widely used herbicide, causes wet dog shakes (WDS), which involve the central opioid system, in rats. A non-selective nitric oxide (NO) synthase (NOS) inhibitor, N(omega)-nitro-L-arginine (L-NA), but not its less active enantiomer, N(omega)-nitro-D-arginine, decreased the PQ-induced WDS in a dose-related manner. A selective neuronal NOS inhibitor in vivo, 7-nitroindazole, also decreased the PQ-induced WDS. Although an opioid receptor antagonist, naloxone, reversed the suppressive effect of these NOS inhibitors on the PQ-induced WDS, L-arginine, an NO precursor, had no effect on it. These findings suggest that the suppression of the PQ-induced WDS by NOS inhibition is associated with the central opioid system and is insusceptible to exogenous L-arginine.

UI MeSH Term Description Entries
D007191 Indazoles A group of heterocyclic aromatic organic compounds consisting of the fusion of BENZENE and PYRAZOLES. Indazole
D008297 Male Males
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D010269 Paraquat A poisonous dipyridilium compound used as contact herbicide. Contact with concentrated solutions causes irritation of the skin, cracking and shedding of the nails, and delayed healing of cuts and wounds. Methyl Viologen,Gramoxone,Paragreen A,Viologen, Methyl
D012018 Reflex An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006540 Herbicides Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. Algaecide,Algicide,Herbicide,Algaecides,Algicides
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate

Related Publications

S Hara, and T Mukai, and T Kuriiwa, and T Yanase, and K Kurosaki, and S Kano, and T Endo
September 1998, Brain research,
S Hara, and T Mukai, and T Kuriiwa, and T Yanase, and K Kurosaki, and S Kano, and T Endo
March 2002, The International journal of neuroscience,
S Hara, and T Mukai, and T Kuriiwa, and T Yanase, and K Kurosaki, and S Kano, and T Endo
May 2009, Pharmacology, biochemistry, and behavior,
S Hara, and T Mukai, and T Kuriiwa, and T Yanase, and K Kurosaki, and S Kano, and T Endo
July 1981, Physiology & behavior,
S Hara, and T Mukai, and T Kuriiwa, and T Yanase, and K Kurosaki, and S Kano, and T Endo
November 1995, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
S Hara, and T Mukai, and T Kuriiwa, and T Yanase, and K Kurosaki, and S Kano, and T Endo
February 1980, Neuroscience letters,
S Hara, and T Mukai, and T Kuriiwa, and T Yanase, and K Kurosaki, and S Kano, and T Endo
January 1996, Journal of neural transmission (Vienna, Austria : 1996),
S Hara, and T Mukai, and T Kuriiwa, and T Yanase, and K Kurosaki, and S Kano, and T Endo
February 1998, General pharmacology,
S Hara, and T Mukai, and T Kuriiwa, and T Yanase, and K Kurosaki, and S Kano, and T Endo
April 1994, European journal of pharmacology,
S Hara, and T Mukai, and T Kuriiwa, and T Yanase, and K Kurosaki, and S Kano, and T Endo
January 1987, Advances in experimental medicine and biology,
Copied contents to your clipboard!